Mobile Integrated Health for Heart Failure

Not currently recruiting at 2 trial locations
RM
RK
RM
BD
Overseen ByBrock Daniels, MD, MPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Columbia University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests two methods to assist people with heart failure after hospital discharge. One group receives phone check-ins from a Transitions of Care Coordinator, while the other has access to a community paramedic through Mobile Integrated Health, who can visit their home and connect them with an emergency doctor via video if needed. The trial aims to determine which method more effectively reduces hospital readmissions and improves quality of life. Individuals currently hospitalized for heart failure in New York City with Medicare or Medicaid may be suitable candidates. As an unphased trial, this study provides a unique opportunity to contribute to innovative care strategies and potentially improve health outcomes.

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, but you should confirm with the trial coordinators.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that these care methods are safe for patients with heart failure?

Research has shown that Mobile Integrated Health (MIH) and community paramedicine programs can benefit patients after hospital discharge. In these programs, trained paramedics visit patients at home to check vital signs, perform physical exams, and ensure home safety. They can also connect with doctors through video calls if needed.

Most studies focus on how these programs help prevent hospital readmissions and improve quality of life. However, detailed information about safety is limited. Few reports of serious side effects suggest that these programs are generally safe.

These programs have been used in similar situations without major safety issues, indicating they are likely safe for most patients. However, discussing any concerns with a doctor before joining a trial is always important.12345

Why are researchers excited about this trial?

Researchers are excited about the Mobile Integrated Health (MIH) approach for heart failure because it brings healthcare directly to patients' homes through community paramedics. Unlike traditional treatments that often require frequent visits to clinics or hospitals, MIH offers a personalized, in-home care experience that includes a comprehensive health assessment and medication adjustments via telemedicine with an emergency physician. This innovative method not only enhances accessibility but also aims to reduce hospital readmissions by ensuring continuous and convenient care. Additionally, the Transitions of Care Coordinator (TOCC) provides crucial follow-up support through phone calls, addressing patients' clinical and social needs shortly after hospital discharge, which is a proactive step to prevent complications. These approaches collectively offer a more integrated and patient-centered care model, which could greatly improve outcomes for individuals with heart failure.

What evidence suggests that this trial's treatments could be effective for reducing hospital readmissions in heart failure patients?

Research has shown that Mobile Integrated Health (MIH), one of the treatment arms in this trial, can assist people with heart failure by providing home care, potentially improving recovery. Some studies have found that community paramedic visits to patients' homes can help predict and possibly reduce the likelihood of hospital readmissions within 30 days. While one program did not observe a significant decrease in hospital returns, another study suggested that MIH can facilitate the transition from hospital to home care and might enhance patient health. This approach allows for quick medical assistance and adjustments to treatment plans without requiring a hospital visit. Overall, MIH aims to smooth recovery and possibly reduce the need for hospital readmission.25678

Who Is on the Research Team?

LS

Leah Shafran Topaz, BPT, MSc

Principal Investigator

Weill Medical College of Cornell University

RM

Ruth M. Masterson Creber, PhD, MSc, RN

Principal Investigator

Columbia University

Are You a Good Fit for This Trial?

This trial is for Medicare or Medicaid recipients with heart failure in NYC (Manhattan, Brooklyn, Queens, Bronx) who are getting out of the hospital. It's not for those who don't speak English, Spanish, Mandarin, or French; have dementia/psychosis; will go to/receive care from a nursing facility/rehab/hospice; or await a heart transplant/LVAD.

Inclusion Criteria

Live in NYC
I am currently receiving care at NewYork Presbyterian or Mount Sinai.
I receive Medicare or Medicaid benefits.
See 1 more

Exclusion Criteria

I will be, or am currently living in, a skilled nursing facility or rehab center.
Current left ventricular assist device (LVAD)
I am on the waiting list for a heart transplant.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

During hospitalization

Treatment

Participants receive either Mobile Integrated Health or Transitions of Care Coordinator interventions after hospital discharge

30 days
Follow-up phone calls and home visits as needed

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Mobile Integrated Health
  • Transitions of Care Coordinator
Trial Overview The study compares two post-hospitalization care methods: phone check-ins by a Transitions of Care Coordinator and at-home medical services by Mobile Integrated Health with community paramedics and video calls with doctors. The goal is to see which method better reduces hospital readmissions and improves life quality within 30 days after discharge.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Mobile Integrated Health (MIH)Experimental Treatment1 Intervention
Group II: Transitions of care coordinator (TOCC)Active Control1 Intervention

Mobile Integrated Health is already approved in United States for the following indications:

🇺🇸
Approved in United States as Mobile Integrated Health for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Columbia University

Lead Sponsor

Trials
1,529
Recruited
2,832,000+

Weill Medical College of Cornell University

Lead Sponsor

Trials
1,103
Recruited
1,157,000+

Patient-Centered Outcomes Research Institute

Collaborator

Trials
592
Recruited
27,110,000+

Published Research Related to This Trial

Effective coordination of care during patient transitions between healthcare settings is essential to prevent fragmented care and reduce hospital readmissions.
Implementing evidence-based communication strategies can significantly improve patient outcomes and lower healthcare costs.
Exploring Transitional Care: Evidence-Based Strategies for Improving Provider Communication and Reducing Readmissions.Mansukhani, RP., Bridgeman, MB., Candelario, D., et al.[2020]
Implementing multicomponent transition management (TM) services within a Patient Centered Medical Home (PCMH) model significantly reduced the 30-day hospital readmission rate from 17.9% to 8.0% among 118 patients.
The average time to hospital readmission was extended from 95 days to 115 days, indicating that integrated care coordination can improve patient outcomes after hospital discharge.
Impact of an integrated transition management program in primary care on hospital readmissions.Farrell, TW., Tomoaia-Cotisel, A., Scammon, DL., et al.[2016]
The MIH-CP transitional care program did not significantly reduce 30-day inpatient readmissions compared to matched controls, indicating that the program may not have the intended impact on short-term hospital utilization.
However, patients enrolled in the MIH-CP program experienced a higher rate of observation hospitalizations within 30 days of discharge, suggesting that while the program did not lower readmissions, it may have led to increased short-term monitoring in a hospital setting.
The effect of a mobile integrated health program on health care cost and utilization.Gingold, DB., Liang, Y., Stryckman, B., et al.[2022]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40952734/
The Mighty-Heart Randomized Clinical TrialObjective: To compare the effectiveness adding mobile integrated health (MIH) to a transitions of care coordinator for improving health ...
Home-Based Heart Failure Program: A Win for Some, But ...A program that delivered in-home visits from a trained paramedic team to people with heart failure did not significantly reduce 30-day hospital readmissions or ...
Community Paramedics are Effective at Predicting 30-day ...Objective: Heart failure (HF) patients are at high risk for 30-day hospital readmission which is a negative predictor of patient-centered ...
Community Paramedic Home Care Program for Acute ...Community paramedic (CP) mobile integrated healthcare program (MIHP) home visits for acute decompensated heart failure (HF) may ease care transitions, reduce ...
Mobile Integrated Health vs a Transitions of Care ...This randomized clinical trial assesses the effectiveness of mobile integrated health compared with a transitions of care coordinator alone ...
Using Mobile Integrated Health and telehealth to support ...The coprimary study outcomes are all-cause 30-day hospital readmissions and quality of life measured with the Kansas City Cardiomyopathy ...
Mobile Integrated Healthcare - Community Paramedicine: ...To assess the efficacy of the Mobile Integrated Healthcare - Community Paramedicine (MIH-CP) program in the reduction of heart failure (HF) readmissions.
Mobile Integrated Health Care and Community ParamedicineThere have been few data published on the safety, cost-effectiveness, and feasibility of mobile integrated health care and community paramedicine programs.15 ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security